allulose glp-1 weight loss release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose Allulose may increase GLP-1 -

For GLP-1 Users, Fueling Must Be Even More Strategic GLP-1 agonists (Ozempic, Wegovy, Mounjaro, etc.) slow gastric emptying and suppress appetite (4), which can make it difficult to consume enough nutrient-dense food for energy and thermoregulation

Clinical trials showed blood pressure reductions of 6-8 mmHg systolic on average

If it continues, consult your provider

Feedback suppression of meal-induced glucagon-like peptide-1 (GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment

This gradual accumulation is intentional and provides consistent therapeutic benefit